ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: Teva Pharmaceutical Industries Limited Sponsored A (TEVA) Report Updated: Nov 24, 2014 | Print This Page

Teva Pharmaceutical Industries Limited Sponsored A© quotemedia

Company Profile

Teva Pharmaceutical Industries Limited develops, manufactures, and sells pharmaceutical products worldwide. It offers generic pharmaceutical products in various dosage forms, including tablets, capsules, ointments, creams, liquids, injectables, and inhalants; and provides basic chemical entities, as well as specialized product families, such as sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances. Its principal branded pharmaceutical products comprise Copaxone for multiple sclerosis; Provigil and Nuvigil for the treatment of excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work disorder; Azilect for the treatment of Parkinson’s disease; Fentora and Actiq for the treatment of pain in opioid-tolerant adult patients with cancer; Amrix for muscle spasm in acute, painful, musculoskeletal conditions; ProAir for the treatment of bronchial spasms; and Qvar for long-term control of chronic bronchial asthma. The company also offers Treanda for the treatment of chronic lymphocytic leukemia and indolent B-cell non-Hodgkin’s lymphoma; Tevagrastim/Ratiograstim that stimulate the production of white blood cells; Eporatio, which stimulates the production of red blood cells; Plan B One-Step for emergency contraception; ParaGard, a non hormonal intrauterine contraceptive; hormone therapy treatments for menopause/perimenopause; and therapies for infertility and urinary incontinence. In addition, it produces active pharmaceutical ingredients in the areas of respiratory, cardiovascular, anti-cholesterol, central nervous system, dermatological, hormones, anti-inflammatory, oncology, immunosuppressants, and muscle relaxants. Further, the company offers animal health products; and distributes third party products. It has co-operation agreements with Lonza Group Ltd. for biologic pharmaceuticals; and OncoGenex Pharmaceuticals, Inc. for OGX-011. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.

Recent News: Teva Pharmaceutical Industries Limited Sponsored A